Rachel Tsui

There’s a new trend in the biotech startup world, and that’s the increasing presence of biotech startup incubators across the country. Many...

Scientist released a press release announcing it raised $3 million in Series B Funds to “Grow Science as a Server” Platform. Scientist is often...

The increasing awareness of the scientific research community on the importance of open access and openscience has given rise to a new funding...

While we previously discussed how rare disease research has dramatically increased in both academic and industrial research, clinical trials of...

Computational drug discovery has reduced the time and money required for research and development while increasing the potential number of drug...

Last year, Scientist announced our winners for the Rare Disease Challenge, as part of our efforts to raise awareness for rare diseases. We know how...

We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug...

Collaborative Drug Discovery (CDD) is hosting their users and community meeting at the UCSF Mission Bay Conference Center in San Francisco on...

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...

Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope...